Canadian Medication Cost Savings Associated with Combinatorial Pharmacogenomic Guidance for Psychiatric Medications

OBJECTIVE: To estimate Canadian pharmacy cost savings associated with psychiatric medication prescribing that is guided by combinatorial pharmacogenomic testing in patients switching or augmenting their psychiatric medication. METHODS: Pharmacy claims data from a United States (US) pharmacy benefit...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanner, Julie-Anne, Brown, Lisa C, Yu, Kunbo, Li, James, Dechairo, Bryan M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6910088/
https://www.ncbi.nlm.nih.gov/pubmed/31849503
http://dx.doi.org/10.2147/CEOR.S224277

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6910088/
https://www.ncbi.nlm.nih.gov/pubmed/31849503
http://dx.doi.org/10.2147/CEOR.S224277

Ejemplares similares